The customer received a questionable high crep2 creatinine plus ver.2 result for one sample from a patient.The customer had three serum tubes drawn from the patient which were labeled with two different samples ids.All three samples were processed via the pvt (p471/p612) preanalytic system and two of the samples were tested on cobas 8000 c (701) module serial number (b)(4).One sample with (b)(6) (sample b) had a creatinine result of 314 umol/l and the sample with (b)(6) (sample c) had a result of 177 umol/l.Both results were reported outside of the laboratory and were questioned by the physician.There was no allegation of an adverse event.The creatinine reagent lot number was 283369.The expiration date was requested but was not provided the laboratory checked the labeling of the tubes, all other results for the samples, and the blood type of the samples.The customer was certain both of these samples were from the same patient.On (b)(6) 2017 the laboratory retested all three samples with both crep2 creatinine plus ver.2 and creatinine jaffe methods as part of troubleshooting.The results showed the same discrepancy for the one suspect sample tube (sample b).The customer suspected the sample tube had been contaminated.The field service representative checked the instrument and performed minor adjustments.Afterward, the instrument performed within specification.Review of the provided reaction data confirmed the contamination and excluded interference from the patient's myeloma.As no other analytes were affected, a general patient or analyzer issue was not suspected.As only one of the samples was affected, an interference with the patient's medication or sample probe carry over could be excluded.The source of the contamination was unknown, but was likely the pvt (p471/p612) preanalytic system.
|